These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 24910584)

  • 1. Non-monotonic dose responses in studies of endocrine disrupting chemicals: bisphenol a as a case study.
    Vandenberg LN
    Dose Response; 2014 May; 12(2):259-76. PubMed ID: 24910584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonmonotonic Dose-Response Curves Occur in Dose Ranges That Are Relevant to Regulatory Decision-Making.
    Hill CE; Myers JP; Vandenberg LN
    Dose Response; 2018; 16(3):1559325818798282. PubMed ID: 30228814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose effects and non-monotonic dose responses for endocrine active chemicals: science to practice workshop: workshop summary.
    Beausoleil C; Ormsby JN; Gies A; Hass U; Heindel JJ; Holmer ML; Nielsen PJ; Munn S; Schoenfelder G
    Chemosphere; 2013 Oct; 93(6):847-56. PubMed ID: 23932820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CLARITY-BPA academic laboratory studies identify consistent low-dose Bisphenol A effects on multiple organ systems.
    Prins GS; Patisaul HB; Belcher SM; Vandenberg LN
    Basic Clin Pharmacol Toxicol; 2019 Aug; 125 Suppl 3(Suppl 3):14-31. PubMed ID: 30207065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spindle abnormalities and chromosome misalignment in bovine oocytes after exposure to low doses of bisphenol A or bisphenol S.
    Campen KA; Kucharczyk KM; Bogin B; Ehrlich JM; Combelles CMH
    Hum Reprod; 2018 May; 33(5):895-904. PubMed ID: 29538760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine-disrupting chemicals, epigenetics, and skeletal system dysfunction: exploration of links using bisphenol A as a model system.
    Xin F; Smith LM; Susiarjo M; Bartolomei MS; Jepsen KJ
    Environ Epigenet; 2018 Apr; 4(2):dvy002. PubMed ID: 29732168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of study design and sex-differences on results from developmental neurotoxicity studies of bisphenol A: implications for toxicity testing.
    Beronius A; Johansson N; Rudén C; Hanberg A
    Toxicology; 2013 Sep; 311(1-2):13-26. PubMed ID: 23485653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of polycarbonate monomer bisphenol-A in insulin resistance.
    Pjanic M
    PeerJ; 2017; 5():e3809. PubMed ID: 28929027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methodological issues in human studies of endocrine disrupting chemicals.
    Lee DH; Jacobs DR
    Rev Endocr Metab Disord; 2015 Dec; 16(4):289-97. PubMed ID: 26880303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine and behavioral implications of endocrine disrupting chemicals in quail.
    Ottinger MA; Abdelnabi MA; Henry P; McGary S; Thompson N; Wu JM
    Horm Behav; 2001 Sep; 40(2):234-47. PubMed ID: 11534988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probabilistic assessment method of the non-monotonic dose-responses-Part I: Methodological approach.
    Chevillotte G; Bernard A; Varret C; Ballet P; Bodin L; Roudot AC
    Food Chem Toxicol; 2017 Aug; 106(Pt A):376-385. PubMed ID: 28579547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-specific enhanced behavioral toxicity induced by maternal exposure to a mixture of low dose endocrine-disrupting chemicals.
    Sobolewski M; Conrad K; Allen JL; Weston H; Martin K; Lawrence BP; Cory-Slechta DA
    Neurotoxicology; 2014 Dec; 45():121-30. PubMed ID: 25454719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the Endocrine-Disrupting Chemical Bisphenol A (BPA) in Human Placentation.
    de Aguiar Greca SC; Kyrou I; Pink R; Randeva H; Grammatopoulos D; Silva E; Karteris E
    J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32028606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of the Possible Harm of Endocrine-Disrupting Chemicals in Humans: Ongoing Debates and Key Issues.
    Lee DH
    Endocrinol Metab (Seoul); 2018 Mar; 33(1):44-52. PubMed ID: 29589387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of diethylene glycol dibenzoate and Bisphenol A on the lipid metabolism of Danio rerio.
    Santangeli S; Notarstefano V; Maradonna F; Giorgini E; Gioacchini G; Forner-Piquer I; Habibi HR; Carnevali O
    Sci Total Environ; 2018 Sep; 636():641-655. PubMed ID: 29723837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Environ Toxicol Pharmacol; 2020 Aug; 78():103396. PubMed ID: 32391796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine disrupting chemicals: effects on human male reproductive health.
    Murray TJ; Lea RG; Abramovich DR; Haites NE; Fowler PA
    Early Pregnancy (Cherry Hill); 2001 Apr; 5(2):80-112. PubMed ID: 11753523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent and combined effects of Bisphenol A and Diethylhexyl Phthalate on gestational outcomes and offspring development in Sprague-Dawley rats.
    Dagher JB; Hahn-Townsend CK; Kaimal A; Mansi MA; Henriquez JE; Tran DG; Laurent CR; Bacak CJ; Buechter HE; Cambric C; Spivey J; Chuang YJ; Campbell EJ; Mandal A; Mohankumar PS; MohanKumar SMJ
    Chemosphere; 2021 Jan; 263():128307. PubMed ID: 33297244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Toxicol In Vitro; 2020 Sep; 67():104861. PubMed ID: 32360643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    J Toxicol Environ Health A; 2020 Jul; 83(13-14):485-494. PubMed ID: 32552445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.